Navigation Links
DAVISCO Foods International, Inc. and MEGGLE Group Announce a Joint Venture for the Production of Pharmaceutical Lactose.
Date:11/16/2009

EDEN PRAIRIE, Minn., Nov. 16 /PRNewswire/ -- Announced on November 06, 2009 by Mr. Mark Davis, the President and CEO of DAVISCO Foods International Inc., and the Board of MEGGLE Group of Wasserburg, Germany, represented by Drs Sil H. van der Ploeg, CEO, and Mr. Christian Sedlatschek, CFO, the companies are entering a long-term partnership for the production of pharmaceutical lactose in the United States.

DAVISCO Foods is an international cheese and food ingredient company, founded in 1943, headquartered in Le Sueur, MN., a privately-held, family-owned business. DAVISCO is a company committed to technical advancement, customer service, and the production of superior quality products.

The holding group MEGGLE AG, whose headquarters are in Wasserburg, Germany was founded in 1887 and bundles the activities of the different companies within the milk and whey-processing business group. This structure embodies flexibility and decisiveness on the one hand and the traditional character of the dairy with its long history of milk-processing on the other. The Business Group Excipients & Technology is considered the leading producer of pharmaceutical lactose and excels in particular in offering High - Tech, innovative excipients to the pharmaceutical industry worldwide.

DAVISCO will expand their existing lactose production at the Le Sueur facility to accommodate additional production lines for the production of pharmaceutical lactose utilizing state-of-the-art processing technology.

MEGGLE will provide the technical marketing, sales and distribution for the pharmaceutical lactose products.

"DAVISCO Foods Intl. Inc. is excited and honored to engage in a joint venture with the MEGGLE Company to produce pharmaceutical lactose products. We have had a close and rewarding relationship for years with MEGGLE and have respected and admired their many achievements. The joint venture will produce the same high quality products and provide the same service that MEGGLE has historically produced and provided." Mr. Mark Davis, President DAVISCO Food International Inc.

"MEGGLE highly appreciates the partnership with DAVISCO. This is an important step in our strategy to expand our capacities and at the same time to offer our customers worldwide the security of a second production site." Drs Sil H. van der Ploeg, CEO of MEGGLE

www.DAVISCOFoods.com

www.MEGGLE.com

SOURCE DAVISCO Foods International, Inc.


'/>"/>
SOURCE DAVISCO Foods International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Soyfoods Do Not Impact Sperm Count
2. New Database from ANSI, AAMI, ASTM International, and DIN Provides Centralized Source of Information for Medical Device Professionals
3. Natural Alternatives International, Inc. Announces Filing of Patent Infringement Lawsuit
4. Chindex International, Inc. Reports Second Quarter and First Half Fiscal 2010 Financial Results
5. Chindex International, Inc. to Report Second Quarter Fiscal 2010 Financial Results
6. Medizone International, Inc. (MZEI.PK): Trials of the AsepticSure Hospital Sterilization System Have Begun
7. Arno Therapeutics, Inc. Completes $18 Million Financing and Reverse Merger with Laurier International, Inc.
8. Encorium Group, Inc. Appoints Sari Laitinen to Board of Directors
9. WellTek/MedX Group Completes Major Reorganization
10. Hill-Rom and Encompass Group Form Joint Venture
11. GSI Group Inc. Announces NASDAQ Delisting and Reports Progress on Revenue Recognition Review and Preliminary Third Quarter 2009 Bookings and Cash Balance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Story Highlights: ... the health care industry is causing providers to review ... Deloitte offers a suite of solutions for health care ... cost optimization: labor resource analysis, revenue cycle optimization and ... outcomes and better economics ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... Research and Markets has ... 2015-2025: Applications, Technologies, Forecasts" report to their ... Electronics, Smart Skin, Structural Health Monitoring, Composite Smart ... electronics involves electronic and/or electrical components and circuits ... structures such as vehicle bodies or conformally placed ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... a whole new perspective by using the title layers in ProSlice Levels to ... ProSlice Levels contains over 30 Different presets to choose from. FCPX users ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... ... fertility once they have been diagnosed with endometriosis. These women need a treatment ... also require a comprehensive approach that can help for preservation of fertility and ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
Breaking Medicine News(10 mins):